A detailed history of Brave Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Brave Asset Management Inc holds 6,162 shares of ABT stock, worth $717,256. This represents 0.16% of its overall portfolio holdings.

Number of Shares
6,162
Previous 6,262 1.6%
Holding current value
$717,256
Previous $711,000 9.99%
% of portfolio
0.16%
Previous 0.18%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$100.73 - $112.44 $10,073 - $11,244
-100 Reduced 1.6%
6,162 $640,000
Q1 2024

Apr 29, 2024

BUY
$109.52 - $120.96 $24,313 - $26,853
222 Added 3.68%
6,262 $711,000
Q4 2023

Jan 18, 2024

SELL
$90.19 - $110.4 $4,870 - $5,961
-54 Reduced 0.89%
6,040 $664,000
Q3 2023

Oct 13, 2023

SELL
$95.53 - $114.62 $16,717 - $20,058
-175 Reduced 2.79%
6,094 $590,000
Q1 2023

Apr 12, 2023

BUY
$96.86 - $114.01 $9,686 - $11,401
100 Added 1.62%
6,269 $634,000
Q1 2022

Apr 22, 2022

SELL
$114.02 - $139.04 $5,701 - $6,952
-50 Reduced 0.8%
6,169 $730,000
Q4 2021

Jan 21, 2022

SELL
$115.53 - $141.46 $5,660 - $6,931
-49 Reduced 0.78%
6,219 $875,000
Q3 2021

Nov 02, 2021

BUY
$116.66 - $129.06 $11,549 - $12,776
99 Added 1.6%
6,268 $740,000
Q2 2021

Jul 27, 2021

SELL
$105.79 - $124.53 $30,150 - $35,491
-285 Reduced 4.42%
6,169 $715,000
Q1 2021

Apr 26, 2021

BUY
$108.84 - $128.23 $702,453 - $827,596
6,454 New
6,454 $773,000
Q4 2020

Jan 27, 2021

SELL
$105.0 - $114.42 $310,170 - $337,996
-2,954 Closed
0 $0
Q1 2020

Apr 16, 2020

BUY
$62.82 - $91.86 $19,097 - $27,925
304 Added 11.47%
2,954 $233,000
Q4 2019

Jan 17, 2020

SELL
$78.51 - $87.4 $7,851 - $8,740
-100 Reduced 3.64%
2,650 $230,000
Q2 2019

Aug 05, 2019

BUY
$72.88 - $85.0 $7,288 - $8,500
100 Added 3.77%
2,750 $231,000
Q1 2019

May 03, 2019

BUY
$66.22 - $80.06 $175,483 - $212,159
2,650 New
2,650 $212,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $204B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Brave Asset Management Inc Portfolio

Follow Brave Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brave Asset Management Inc with notifications on news.